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TGFβ1 – induced recruitment of 
human bone mesenchymal stem 
cells is mediated by the primary 
cilium in a SMAD3-dependent 
manner
Marie-Noëlle Labour1,2,3, Mathieu Riffault1,2,4, Søren T. Christensen5 & David A. Hoey1,2,3,4
The recruitment of mesenchymal stem cells (MSCs) is a crucial process in the development, 
maintenance and repair of tissues throughout the body. Transforming growth factor-β1 (TGFβ1) is a 
potent chemokine essential for the recruitment of MSCs in bone, coupling the remodelling cycle. The 
primary cilium is a sensory organelle with important roles in bone and has been associated with cell 
migration and more recently TGFβ signalling. Dysregulation of TGFβ signalling or cilia has been linked 
to a number of skeletal pathologies. Therefore, this study aimed to determine the role of the primary 
cilium in TGFβ1 signalling and associated migration in human MSCs. In this study we demonstrate that 
low levels of TGFβ1 induce the recruitment of MSCs, which relies on proper formation of the cilium. 
Furthermore, we demonstrate that receptors and downstream signalling components in canonical TGFβ 
signalling localize to the cilium and that TGFβ1 signalling is associated with activation of SMAD3 at the 
ciliary base. These findings demonstrate a novel role for the primary cilium in the regulation of TGFβ 
signalling and subsequent migration of MSCs, and highlight the cilium as a target to manipulate this key 
pathway and enhance MSC recruitment for the treatment of skeletal diseases.
The adult skeleton is a dynamic structure that is continuously adapting and remodelling to meet the demands 
of the local biochemical and biophysical environment. This is achieved through tightly regulated and coordi-
nated bone resorption by osteoclasts followed by bone formation by mesenchymal derived osteoblasts. Due to the 
non-proliferative state and short lifespan of the osteoblast, continued bone formation requires the replenishment 
of the exhausted osteoblast from a mesenchymal stem cell (MSC) population1. Tight coordination of this process 
is essential as defects in MSC recruitment have been associated with a number of skeletal pathologies including 
osteoporosis. Indeed, osteoporotic patients have reduced defect and fracture healing rates2–4 and transplanted 
osteoporotic MSCs demonstrate significantly reduced homing to a fracture site4. Deciphering the mechanisms by 
which MSCs are recruited to sites of bone formation is critical to the development of novel anabolic therapies for 
osteoporosis and to tissue engineering strategies for treating bone defects and fractures.
Primary cilia are membrane-bound, microtubule-based organelles that extend as solitary structures from a 
modified centriole (basal body) at the surface of most mammalian cell types5, including human MSCs (hMSCs)6,7. 
Primary cilia function as unique sensory units with a diverse complement of receptors and ion channels that 
detect extracellular cues and transmit signalling information to the cell to control cellular and physiological 
processes during development and in tissue homeostasis7–10. Primary cilia are assembled and maintained by a 
process known as intraflagellar transport (IFT)11, which when defective, leads to aberrant cell signalling and 
numerous clinical disorders termed ciliopathies, including skeletal abnormalities12,13. Indeed, several studies 
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have demonstrated an important role for the primary cilium in adult bone where the organelle is required for 
loading-induced osteogenesis14–20. In mesenchymal progenitors the cilium is also involved in biochemical and 
biophysical sensing that dictates early osteogenic responses6,21–23 and acts as a signaling hub regulating Wnt sign-
aling, a critical pathway in skeletal tissue24. Recently, Chen et al. demonstrated that bone formation, in response 
to loading, was significantly inhibited in mice subjected to a conditional knock-out of the primary cilium within 
the bone marrow, including the stem cell population25. Interestingly, this occurred due to a decrease in the area 
of active mineralizing surface rather than the rate of mineralization suggesting that the cilium may be involved 
in osteoprogenitor cell recruitment. Similarly, the primary cilium plays a critical role in regulating directional 
cell migration in fibroblasts and endothelial cells, with mice with defective cilia exhibiting significantly reduced 
wound healing rates due to a decrease in cell recruitment to sites of injury26,27.
Transforming Growth Factor Beta 1 (TGFβ 1) is a ubiquitous growth factor in skeletal tissue, playing major 
roles in development and maintenance of bone metabolism through the control of cellular proliferation, differen-
tiation, matrix deposition and migration28. In bone, TGFβ 1 is stored in the extracellular matrix in a latent form 
and is activated during osteoclast-mediated resorption29, and is released in response to loading30, and as a result 
of fracture31,32. Tang et al.29 demonstrated that TGFβ 1 is essential for the recruitment of MSCs to the bone surface, 
whereby TGFβ 1 is released by osteoclast mediated resorption generating a gradient that induces the recruitment 
of MSCs in a SMAD3-dependent manner. A number of skeletal pathologies such as osteopenia, osteoarthritis or 
Camurati-Engelmann disease have been associated with a deficiency or overexpression of TGFβ 1 and associated 
signalling29,33–36. These studies highlight the critical role of TGFβ 1 in maintaining bone homeostasis, but also 
importantly, the need for tight regulation of this pathway. TGFβ 1 signals through a heteromeric complex, within 
which the TGFβ type II receptor (TGFβ RII) transphosphorylates and activates the type I receptor (TGFβ RI). 
TGFβ RI in turn initiates SMAD signalling by phosphorylating SMAD2/3, followed by translocation of same to 
the nucleus37. TGFβ receptors have been shown to undergo regulated microdomain clustering, multimerisation 
and internalisation, mechanisms that affect TGFβ 1 binding and downstream effector recruitment and there-
fore play crucial roles in the regulation of signal intensity and duration38,39. Very recent studies have elegantly 
demonstrated discrete spatial organisation of the TGFβ receptors within focal adhesions40 and intriguingly in and 
around the primary cilium in fibroblasts and human embryonic stem cells (hESC) as well as in a P19.CL6 mouse 
cancer stem cell line41,42. In fibroblasts, stimulation with TGFβ 1 leads to accumulation and clathrin-mediated 
internalization of the receptors at the ciliary pocket for activation of SMAD2/3, which is increased in stem cells 
undergoing cardiomyogenesis41.
As MSC recruitment is pivotal for bone maintenance and repair and may be targeted as potential therapy 
to treat skeletal defects and disease, this study aimed to determine the role of the primary cilium in human 
MSC recruitment and elucidate the mechanisms by which the cilium may mediate this process. In this study, we 
demonstrate that TGFβ 1 significantly induces human MSC recruitment in a concentration-dependent manner 
and that TGFβ 1-induced recruitment is regulated by the primary cilium. Furthermore, we show that the cilium 
mediates this response through distinct spatial localisation of TGFβ receptors and signalling components at the 
primary cilium, whereby TGFβ 1-mediated activation of SMAD3 takes place at the ciliary base. This study there-
fore demonstrates that signalling through the primary cilium is necessary for the sensing of a TGFβ 1 chemotactic 
gradient in human bone mesenchymal stem cells demonstrating a novel mechanism of TGFβ signal regulation 
and recruitment in stem cells, and highlights the primary cilium as a potential target to enhance MSC recruitment 
and bone formation in orthopaedic disease.
Results
TGFβ1 induces recruitment and inhibits osteogenesis of human MSCs at low concentra-
tions. As there are a limited number of often conflicting studies on the effect of TGFβ 1 on hMSC behav-
iour28,43, we first examined the effect of TGFβ 1 concentration on human MSC migration, proliferation and 
osteogenic differentiation (Fig. 1). With regards to hMSC recruitment, the effect of TGFβ 1 concentration revealed 
a bell shaped profile centred on low concentrations promoting a 2.1 and 2-fold increase in hMSC migration 
for 0.1 and 1 pg/ml TGFβ 1 respectively when compared to unstimulated control (p < 0.01 and p < 0.05, N = 4) 
(Fig. 1a). The degree of migration at these concentrations was equivalent to 10% serum demonstrating the potent 
chemotactic properties of TGFβ 1. With regards to hMSC proliferation, TGFβ 1 did not induce proliferation at any 
concentration investigated after 3 days (Fig. 1b). The control with 10% FBS demonstrated a significant 2.1-fold 
increase in proliferation (p < 0.001, N = 9), indicating that hMSCs can proliferate during this time interval and 
suggests that TGFβ 1 (0.01–20,000 pg/ml) does not mediate hMSC proliferation. With regards to hMSC oste-
ogenic differentiation, TGFβ 1 was found to have a negative effect on osteogenesis at low and high concentra-
tions. Quantitative real-time PCR analysis revealed no significant changes in RunX2, Osteopontin, BMP2 and 
Osteocalcin gene expression with increasing TGFβ 1 concentration after 14 days treatment (Fig. 1c). Despite a 
lack of significance, Osteopontin expression is slightly increased at 0.1 pg/ml TGFβ 1 compared to control cells, 
while, with the exception of RunX2, the expression of all other genes analysed were decreased with TGFβ 1 con-
centrations greater than 1 ng/ml, suggesting an inhibition of osteogenesis with TGFβ 1 treatment. To confirm 
these results and to assess mineral deposition, Alizarin Red staining and calcium quantification was performed 
after 14 days treatment. Regarding calcium staining, there is no obvious visual difference with increasing TGFβ 1 
treatment (Fig. 1d). However, the quantities of calcium measured after extraction were significantly decreased 
for 0.1 pg/ml, 10 and 20 ng/ml (Fig. 1e) when compared to unstimulated controls, confirming that low and high 
TGFβ 1 concentrations inhibit osteogenic differentiation of hMSCs. Altogether, these data demonstrate that 
TGFβ 1 induces recruitment, does not influence proliferation, and inhibits osteogenesis of hMSCs in a concen-
tration-dependent manner.
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TGFβ receptors are localised and concentrated within the sub-compartment of the primary 
cilium. Given the potent role of TGFβ 1 in mediating hMSC migration demonstrated above, and the poten-
tial role of the primary cilium in regulating MSC recruitment in vivo25, we next examined whether the primary 
cilium may act as a chemosensor for the TGFβ 1 ligand. To this end, we performed immunofluorescence micros-
copy (IFM) analysis on the localization of TGFβ RI as well as TGFβ RII constitutively autophosphorylated on 
tyrosine residue 424 (p-TGFβ RIIY424), which is required for receptor activity44. Following 48 hours of serum 
starvation to promote ciliogenesis, IFM was performed with antibodies against TGFβ RI, p-TGFβ RIIY424 and 
acetylated-α -tubulin (Ac-Tub) to identify the primary cilium. Faint p-TGFβ RIIY424 staining was present through-
out the cytoplasm but interestingly there was a higher concentration of p-TGFβ RIIY424 along the entire length 
of the cilium (Fig. 2a), as previously reported for hESC42. This preferential ciliary localisation was verified by 
fluorescence intensity readings along the cilium demonstrating a 5.6-fold increase of intensity (p < 0.001, n = 9 
ciliated cells) along the cilium when compared to the cytoplasm (Fig. 2b). A similar trend was also found with 
TGFβ RI, with faint staining throughout the cytoplasm and strong concentration of TGFβ RI along the primary 
cilium (Fig. 2c). The fluorescence intensity reading was 3.3-fold higher (p < 0.001, n = 7 ciliated cells) within the 
cilium when compared to the cytoplasm (Fig. 2d). Faint TGFβ RI staining was also found within the nucleus. We 
further quantified the number of ciliated cells, which display this preferential spatial organisation and found that 
TGFβ RI and p-TGFβ RIIY424 co-localize with the cilium in 36.8 ± 26.5% and 76.3 ± 13.9% of ciliated cells (N ≥ 3, 
n ≥ 150 ciliated cells per group), respectively. These data demonstrate that TGFβ receptors are preferentially local-
ised to the primary cilium in hMSCs, indicating that this organelle may be associated with regulation of TGFβ 1 
signalling and recruitment of hMSCs.
TGFβ1-induced recruitment of hMSCs is mediated by the primary cilium. To determine 
whether the primary cilium is required for TGFβ 1–induced recruitment of hMSCs, cells were subjected to 
siRNA-mediated knock-down (KD) of IFT88, which is required for anterograde IFT and thereby formation of the 
primary cilium45–47. Seventy-two hours following transfection, mRNA levels of IFT88 were significantly reduced 
by 80% (p < 0.001, N = 5) when compared to control cells transfected with scrambled siRNA (Fig. 3a). These 
results were confirmed at the protein level with western blot analysis (Fig. 3b). To further confirm a disruption of 
IFT and ciliogenesis, primary cilium incidence and length was quantified by IFM analysis (Fig. 3c). Knock-down 
of IFT88 resulted in a significant decrease in number of ciliated hMSCs (p < 0.001, N = 14, n ≥ 260 cells per 
Figure 1. Effect of TGFβ1 on hMSC migration, proliferation and differentiation. (a) Chemoatxis of hMSC 
in response to 0.01 pg/ml to 10 ng/ml TGFβ 1 expressed as chemotactic index (number of cells per field of view 
normalised to the control). (b) Proliferation of hMSC treated with 0.1 pg/ml − 20 ng/ml TGFβ 1 expressed as 
DNA concentration. (c–e) Osteogenic differentiation of hMSCs after 14 days of treatment with 0.1 pg/ml − 
20 ng/ml TGFβ 1. (c) qPCR analysis of Osteocalcin, Osteopontin, RunX2 and BMP2 expression. (d) Alizarin red 
staining, scale bar 200 μ m. (e) Assessment of mineralisation by calcium concentration measurement. All results 
are expressed as mean ± SEM and analysed using 1 way Anova with Dunnett’s multiple comparison post-test, 
*p < 0.05, **p < 0.01, ***p < 0.001.
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group) and, of the cells that still possessed a cilium, the cilium length was stunted in comparison to scrambled 
controls (p < 0.001, N = 6, n ≥ 60 ciliated cells per group), indicating a defect in IFT (Fig. 3d,e).
As high concentrations of TGFβ 1 has been previously shown to alter cilia length by modulating IFT88 expres-
sion48 and cell morphology by modulating actin organisation, we analysed cilia incidence, cilia length, and the 
actin cytoskeleton in hMSCs following 30 min and 2 hrs treatment of TGFβ 1 at 0.1 pg/ml concentration to mimic 
that at which we observed hMSC recruitment. 0.1 pg/ml TGFβ 1 treatment did not influence cilia incidence, cilia 
length or actin organisation in hMSCs (Figure S1a–c). Furthermore, as IFT88 has also been shown to influence 
actin organization in chondrocytes which may influence cell migration49, the actin organisation was analysed 
following IFT88 KD and compared to scrambled control. There was no observable difference in hMSC actin 
organisation following IFT88 KD (Figure S1d).
Upon verification of a disruption of ciliogenesis, we next examined the migration capacity in IFT88-depleted 
cells. IFT88 KD did not result in any alteration in hMSC migration in the absence of a chemotactic gradient 
(i.e. identical media formulation in the upper and lower chamber) over the 18 hours of the experiment (Fig. 4a). 
Furthermore, in response to a gradient of 10% serum, scrambled siRNA-treated hMSCs responded with a 2.3-fold 
increase in migration (p < 0.001, N = 6) compared to serum free controls, which is in agreement with the pos-
itive control in Fig. 1a, demonstrating that the siRNA treatment alone does not influence hMSC migration. 
Furthermore, IFT88-depleted hMSCs also responded with a 3.8-fold increase in migration in response to 10% 
FBS (p < 0.001, N = 6), indicating that IFT88 is not required for serum-induced hMSC directional migration, 
as previously described for other cell types with defective ciliogenesis26. To determine whether primary cilia 
are required for TGFβ 1–induced recruitment of hMSCs, we investigated the migration capacity of both scram-
bled and IFT88 siRNA-treated hMSCs in response to a gradient of 0.1 pg/ml TGFβ 1. Scrambled siRNA hMSCs 
demonstrated a significant 1.9-fold increase in migration in response to TGFβ 1 (p < 0.01, N = 18) which is in 
agreement with Fig. 1a. In contrast, TGFβ 1-induced migration was blocked in IFT88-depleted hMSCs (Fig. 4c), 
demonstrating that primary cilia are required for the specific recruitment of hMSC induced by TGFβ 1.
Canonical TGFβ signalling components are localised and concentrated at the primary cilium 
in hMSCs. Since canonical TGFβ signalling operates through the phosphorylation of TGFβ RI and SMAD 
transcription factors, we next examined whether TGFβ signalling components localize to the primary cilium, 
including phosphorylated forms of TGFβ RI (p-TGFβ RIS165)50, and receptor- SMADs 2 and 3 (p-SMAD2 and 
p-SMAD3) in addition to the common-mediator SMAD4, which oligomerizes with p-SMAD2/3 for their trans-
location to the nucleus and targeted gene expression in TGFβ signalling37. Similarly to the non-phosphorylated 
form of TGFβ RI, faint p-TGFβ RIS165 staining was present throughout the cytoplasm. However, unlike TGFβ RI 
which co-localised along the length of the cilium, p-TGFβ RIS165 accumulated at the ciliary base in 94.28 ± 6.3% 
of ciliated cells (Fig. 5a) (N = 3, n = 118 cells). Furthermore, the fluorescence intensity of p-TGFβ RIS165 at the 
ciliary base is 3-fold higher than that within the cytoplasm, suggesting a higher concentration at the ciliary region 
(Fig. 5b) (N = 3, n = 10 cells). Phospho-SMAD2 was present throughout the cytoplasm with increased staining 
within the nucleus suggesting that there is a basal level of TGFβ signalling within hMSCs (Fig. 5c). Similar to that 
Figure 2. TGFβ receptors localise to the primary cilia in human MSC. (a,b) Immunocytochemistry analysis 
of the cilia (identified by arrows) using anti-acetylated-α -tubulin in red, constitutively active TGFβ RII (p-TGFβ 
RIIY424) (a) and TGFβ RI (b) in green and nucleus in blue (DAPI). Scale bar 5 μ m and 1 μ m in the enlarged 
pictures. (c,d) Fluorescence intensity analysis of the levels of p-TGFβ RIIY424 (c) and TGFβ RI (d). Intensity 
profile of Acetylated-α -tubulin (red) and receptors (green) along the cilia (left panel) and analysis of the average 
intensity in the cilia and cytoplasm (right panel). Statistical analysis using Student’s t-test, ***p < 0.001.
www.nature.com/scientificreports/
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seen with TGFβ Rs, p-SMAD2 was found to co-localise with the primary cilium in 31.7 ± 40% of ciliated cells 
(N = 3, n = 140 cells). The fluorescence intensity of p-SMAD2 within the cilium was 3.3-fold higher than that of 
the cytoplasm (p < 0.001, n = 7 ciliated cells), (Fig. 5d). Furthermore, p-SMAD3 was also found throughout the 
cytoplasm but exhibited a more concentrated nuclear localisation. Interestingly, p-SMAD3 also co-localised to 
the primary cilium in 81 ± 9.6% of ciliated cells (Fig. 5e) (N = 11, n = 479 cells), but with intense concentrations 
at the ciliary base rather than along the cilium, demonstrating a 16-fold increase (p < 0.001, n = 7 ciliated cells) in 
relative levels compared to the cytoplasm (Fig. 5f), mirroring that which was observed with p-TGFβ RIS165. Similar 
to p-SMAD2, SMAD4 was present throughout the cytoplasm and nucleus but also co-localised along the entire 
length of the cilium (Fig. 5g,h) with a 3-fold increase in intensity compared to the cytoplasm (p < 0.001, n = 9 cil-
iated cells) in 50.6 ± 32.7% of ciliated cells (N = 3, n = 147 cells). These data demonstrate that the phosphorylated 
form of TGFβ RI and downstream effector SMAD proteins are preferentially localised to the primary cilium of 
hMSCs, with distinct spatial organisation within or at the base of the organelle.
Disruption of the primary cilium inhibits TGFβ1-induced activation of SMAD3. Previous studies 
showed that SMAD3 is primarily responsible for TGFβ 1–induced migration of bone MSCs29. To investigate the 
role of the cilium in TGFβ -mediated SMAD signalling in hMSCs, we initially stimulated cells for 30 minutes and 
2 hours with 0.1 pg/ml TGFβ 1 followed by ELISA for quantification of phosphorylation levels of SMAD2/3 and 
specifically SMAD3 alone. Since no detectable change in phosphorylation of either SMAD2/3 or specifically 
SMAD3 was found at this low concentration of the ligand (Fig. 6a,d), we stimulated cells with 1 pg/ml TGFβ 1, 
which also increases hMSC migration (Fig. 1a). In these experiments we observed a significant increase in 
phosphorylation of both SMAD2/3 and SMAD3 (p < 0.01, N = 3–5 for p-SMAD2/3, and p < 0.01, N = 8–10 for 
p-SMAD3) following 30 minutes stimulation (Fig. 6a,d). To determine whether the primary cilium is required for 
increased phosphorylation of these receptor SMADs, ciliogenesis was transiently inhibited by siRNA-mediated 
KD of IFT88 (Fig. 3). KD of IFT88 did not affect basal levels of p-SMAD2/3 in hMSCs when compared to 
Figure 3. Knockdown of IFT88 in hMSCs impairs cilia formation/maintenance. (a,b) Efficiency of IFT88 
siRNA transfection on IFT88 mRNA expression analysed using qPCR (a) and Western blot (b). Expanded 
Western blot can be seen in Supplemental Figure S3. (c) Immunocytochemistry analysis of acetylated-α -tubulin 
(red) and DAPI (blue) showing shortened primary cilia (identified by arrows) after IFT88 KD. Scale bar 5 μ m. 
(d,e) Analysis of the percentage of ciliated cells (d) and cilia length (e) after IFT88 KD. Statistical analysis using 
Student’s t-test. ***p < 0.001.
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scrambled controls (Fig. 6b), and upon stimulation with 1 pg/ml TGFβ 1 for 30 minutes, both IFT88-depleted cells 
and scrambled controls responded with a significant increase in the phosphorylation of SMAD2/3 (p < 0.001, 
N = 4) (Fig. 6c). We next sought to determine whether the primary cilium is required for increased phosphoryl-
ation of receptor SMAD3 specifically. IFT88 KD did not affect basal levels of p-SMAD3 in hMSCs when com-
pared to scrambled controls (Fig. 6e). However, upon stimulation with 1 pg/ml TGFβ 1 for 30 minutes, IFT88 KD 
completely abolished the increase in TGFβ 1-mediated phosphorylation of SMAD3 (Fig. 6f). In line with previ-
ous findings that TGFβ 1–induced migration of MSCs is specifically mediated through the phosphorylation of 
SMAD329, our results support the conclusion that the primary cilium is required for TGFβ 1–induced migration 
of hMSCs through the activation of SMAD3 rather than SMAD2.
TGFβ1-induced canonical signalling takes place at the ciliary base. To further establish the asso-
ciation of TGFβ signalling and the primary cilium in hMSCs, we finally sought to determine whether increased 
phosphorylation of TGFβ RI and SMAD3 takes place at the base of the primary cilium and whether this is dis-
rupted in cells subjected to IFT88 KD. hMSCs were treated with siRNA targeting IFT88 to impair ciliogenesis 
and scrambled siRNA as controls (Fig. 3) and p-TGFβ RIS165 levels at the ciliary base (Fig. S2a–d) and p-SMAD3 
levels at the ciliary base and within the nucleus (Fig. 7a–d) were quantified by IFM analysis. Interestingly, dele-
tion of IFT88 resulted in a small but significant increase in p-TGFβ RIS165 levels at the ciliary base (Figure S2e) 
(p < 0.001, N = 2, n ≥ 32 cells per group). p-TGFβ RIS165 staining within the nucleus was very faint and therefore 
was not analysed. However, removal of the primary cilium did not affect basal levels of p-SMAD3 levels at the 
ciliary base (Fig. 7e) but significantly reduced localization of p-SMAD3 in the nucleus (p < 0.05, N = 3, n ≥ 41 
cells per group) (Fig. 7f). Furthermore, following 1 pg/ml TGFβ 1 stimulation for 30 minutes, the level of TGFβ RI 
and SMAD3 phosphorylation increased at the ciliary base and p-SMAD3 levels increased within the nucleus in 
hMSCs transfected with scrambled siRNA (p < 0.001, p < 0.001 and p < 0.05 respectively, N ≥ 2, n ≥ 32 cells per 
group) (Figures S2f, 7g,h), demonstrating that canonical TGFβ signalling takes place at the base of the primary 
cilium. In contrast, IFT88 KD abolished TGFβ 1-mediated increase in phosphorylations of TGFβ RI at the ciliary 
base (Figure S2f) and SMAD3 at both the ciliary base (Fig. 7g) as well as in the nucleus (Fig. 7h). These data there-
fore demonstrate that TGFβ -induced canonical signalling occurs at the ciliary base followed by translocation to 
the nucleus and that this signalling pathway relies on functional IFT and formation of the primary cilium.
Discussion
The recruitment of mesenchymal stem cells is a crucial process in the development, maintenance or repair of 
nearly every tissue throughout the body. TGFβ 1 is a potent chemokine known to be essential for the recruitment 
of MSCs in bone, coupling the remodelling cycle. Dysregulation of this process has been linked to a number of 
skeletal pathologies28,34,35, which makes TGFβ 1 a choice candidate for the development of therapeutics to promote 
MSC recruitment and restore this process. In this study we demonstrate that TGFβ 1 induces the recruitment 
of human MSCs at low concentrations and, for the first time, established that the primary cilium mediates this 
recruitment process. Furthermore, we demonstrate that the primary cilium facilitates this through regulation of 
TGFβ 1-mediated activation of SMAD3 via distinct spatial localisation of TGFβ receptors and signalling compo-
nents at the cilium. Our findings therefore demonstrate a novel role for the primary cilium in the regulation of 
TGFβ signalling and subsequent migration of human MSCs.
Low concentrations of TGFβ 1 significantly enhance recruitment but inhibit the osteogenic lineage commit-
ment of hMSCs. This chemotactic response is in agreement with previous findings, whereby osteoclast-mediated 
bone resorption releases a gradient of TGFβ 1, which induces the recruitment of progenitor cells to the bone 
surface29. Interestingly, this low concentration also resulted in an inhibitory effect on the osteogenic lineage com-
mitment of hMSCs. Previous studies have demonstrated that TGFβ 1 acts to inhibit late stage osteoblastic differen-
tiation28,43,51. However, our dose response study discovered that this inhibitory effect occurs only at very low and 
high concentrations demonstrating a tri-phasic effect on MSC osteogenesis. The inhibition of osteogenesis at high 
concentrations may relate to a switch in lineage commitment to chondrogenesis52. At low concentrations, despite 
an inhibition of osteogenesis, Osteopontin (OPN) gene expression was increased which complies with finding by 
Figure 4. TGFβ1-induced hMSC chemotaxis requires the primary cilium. (a) Migration in the absence of 
chemotactic gradient of scrambled and IFT88 siRNA transfected cells. (b) Migration capacity of transfected 
cells towards 10% FBS presented as the chemotactic index expressed as mean ± SEM. (c) Chemotaxis of 
scrambled and IFT88 siRNA transfected hMSC towards 0.1 pg/ml TGFβ 1. (b,c) Both scrambled and IFT88 KD 
are normalised to their respective no treatment control. Statistical analysis using Student’s t-test. **p < 0.01, 
***p < 0.001.
www.nature.com/scientificreports/
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Zou et al.53 demonstrating a role for OPN in MSC migration. This may therefore suggest that low concentrations 
of TGFβ 1 may maintain stemness to facilitate migration from the stem cell niche to the bone surface. The potent, 
yet diverse effect of TGFβ 1 concentration on the regulation of different aspects of stem cell behaviour will provide 
useful information to regenerative medicine strategies utilising this growth factor. Our findings therefore support 
a model whereby a TGFβ 1 gradient prevents osteogenic lineage commitment and supports the recruitment of 
MSCs to the area of need demonstrating the important role of this growth factor in MSC physiology.
Human MSCs which have defective primary cilia fail to home in response to TGFβ 1 but interestingly main-
tain the ability for directional migration, demonstrating a novel chemokine specific role for the primary cilium 
in stem cell migration. Interestingly, recent findings by Chen et al. demonstrated a role for the cilium in MSC 
physiology, whereby in mice with defective osteoprogenitor primary cilia, bone formation is diminished due to a 
decrease in active mineralising surface25, suggestive of a defect in osteoprogenitor recruitment. Therefore, reduced 
bone formation in this model may be due to a defect in TGFβ 1-induced MSC migration. Furthermore, previous 
work by Malone et al.15 has demonstrated that increases in OPN expression following mechanical stimulation is 
dependent on the primary cilium in pre-osteoblasts. Therefore TGFβ 1-induced recruitment of hMSCs may be 
mediated by the primary cilium through regulation of OPN expression. The primary cilium has been implicated 
in the migration of other cell types such as fibroblasts, endothelial cells and neurons26,54,55. This phenomenon has 
Figure 5. Canonical TGFβ signalling components localise to the primary cilium in hMSC. 
Immunofluorescence microscopy (IFM) of p-TGFβ RIS165 (a,b) p-SMAD2 (c,d) p-SMAD3 (e,f) and SMAD4 
(g,h). Primary cilia (identified by arrows) were stained with anti-acetylated-α -tubulin (red), nuclei with DAPI 
(blue) and p-TGFβ RIS165 and all SMAD proteins are shown in green. Ciliary base is identified by arrowhead. 
Scale bars 5 μ m and 2 μ m (inserts). (b,d,f,h) Fluorescence intensity profile across the primary cilium and 
average fluorescence intensity analysis in the cilia compared to the cytoplasm. Statistical analysis using Student’s 
t-test. ***p < 0.001.
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been best described in fibroblasts where the cilium mediates the normal chemosensory response to PDGF-AA 
in wound healing26. This cilia-mediated migration was dependent on the ciliary localisation of the PDGF-AA 
receptor56. Hence, our data adds to the growing body of evidence linking the primary cilium to cell migration and 
introduces a novel stem cell recruitment mechanism.
Human MSCs preferentially localise receptors and downstream signalling components of the TGFβ pathway 
to the primary cilium, demonstrating a distinct spatial organisation within the cell. In this study, we have shown 
that TGFβ receptors I and II are localised to the primary cilium of human MSCs suggesting a role for this orga-
nelle as a chemosensor for the TGFβ 1 ligand. Extending from the cell surface into the extracellular milieu, this 
‘antennae-like’ organelle would facilitate receptor-ligand binding, and due to the distinct sub-compartment of 
the cilium, would enable efficient receptor multimerisation and subsequent phosphorylation of the downstream 
effector SMADs. Interestingly, we also observed localisation of p-SMAD2 and SMAD4 within the cilium and 
p-TGFβ RIS165 and p-SMAD3 at the ciliary base. The different localisation of p-SMAD2 and SMAD4 within the 
ciliary compartment and p-TGFβ RIS165 and p-SMAD3 at the base of the cilium may reveal different roles and reg-
ulation of these downstream signalling effectors. Clement et al.41 and Rys et al.40 recently demonstrated discrete 
spatial organisation of TGFβ receptors surrounding primary cilia and integrins respectively suggesting that this 
spatial localisation of receptors is a key mechanism of TGFβ regulation. Therefore, the stem cell primary cilia are 
ideally positioned and equipped to act as both a chemosensor and signalling centre for the TGFβ pathway.
TGFβ 1-induced canonical signalling is mediated by the primary cilium, whereby SMAD3 phosphorylation 
occurs at the ciliary base. We found that TGFβ 1 treatment leads to an increase in p-SMAD3 levels in hMSCs that 
was dependent on the primary cilium. This finding perfectly mirrors the effect of IFT88 KD on TGFβ 1-induced 
stem cell migration. As TGFβ 1-induced migration has previously been shown to be predominately dependent on 
SMAD329, our data indicates that the primary cilium mediates stem cell recruitment via regulation of SMAD3 
signalling. Interestingly, IFT88 KD did not influence the phosphorylation of SMAD2/3 following TGFβ 1 stimula-
tion. As this assay has a greater affinity to p-SMAD2 and given the inhibition of p-SMAD3 signalling with IFT88 
KD, this data indicates that the primary cilium is not required for SMAD2 dependent TGFβ signalling. SMAD2 
and SMAD3 have been shown to have diverse roles in many tissues such as the kidney57 and in breast cancer 
metastasis to bone58. Furthermore, 0.1 pg/ml TGFβ 1 stimulation did not elicit a detectable change in canonical 
TGFβ signalling despite inducing a migratory response. Although this may be due to the sensitivity of the assays 
utilised, TGFβ 1-induced migration at this concentration may be mediated by non-canonical signalling such as 
p-ERK1/241. Primary cilia are known to coordinate many signalling pathways where ligands bind to receptors in 
the ciliary membrane and initiate signal transduction within the ciliary compartment10,41,55,56,59. We found that 
activation of TGFβ signalling resulted in an accumulation of p-TGFβ RIS165 at the ciliary base and p-SMAD3 at 
Figure 6. The primary cilium mediates SMAD3 signalling in hMSCs. (a,c) Analysis of the relative level of 
p-SMAD2/3 by ELISA. Quantification of the relative amount of p-SMAD2/3 with 0.1 pg/ml and 1 pg/ml TGFβ 1  
in control cells (a) and in cells transfected with Scrambled and IFT88 siRNA before (b) and after treatment 
with 1 pg/ml TGFβ 1 for 30 minutes (c). Both scrambled and IFT88 KD are normalised to their respective no 
TGFβ 1 treatment control. (d–f) Analysis of the relative quantity of p-SMAD3 by ELISA. Quantification of the 
relative amount of p-SMAD3 with 0.1 pg/ml and 1 pg/ml TGFβ 1 in control cells (d) and in cells transfected 
with Scrambled and IFT88 siRNA without (e) and with treatment with 1 pg/ml TGFβ 1 (f). Both scrambled 
and IFT88 KD are normalised to their respective no TGFβ 1 treatment control. Statistical analysis using one-
way Anova with Dunnett’s multiple comparison post-test (a,d), Student’s t-test (b,c,e,f). * p < 0.05, **p < 0.01, 
***p < 0.001.
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the ciliary base and within the nucleus and this accumulation was once again dependent on the primary cilium. 
Interestingly, deletion of IFT88 resulted in a slight increase in p-TGFβ RIS165 at the ciliary base in the absence of 
TGFβ but did not influence p-SMAD3 levels, indicating that a basal level of TGFβ signalling can occur independ-
ent of IFT, most likely initiating at focal adhesions as demonstrated by Rys et al.60. Our findings are commensurate 
to a model of cilia-mediated TGFβ signalling introduced by Clement et al. whereby upon ligand binding, TGFβ 
RII/I, located along the cilium are trafficked to the ciliary base and undergo clathrin-dependent endocytosis 
facilitating phosphorylation of downstream SMADs at the ciliary base, followed by translocation to the nucleus41. 
Although receptor trafficking and receptor endocytosis at the ciliary base remains to be confirmed in human 
MSCs, the data presented here demonstrates that IFT88 regulates TGFβ signalling, demonstrating a novel mech-
anism of TGFβ pathway regulation.
This study presents evidence that TGFβ 1 signalling through the primary cilium is necessary for the sensing 
of a TGFβ 1 chemotactic gradient in human bone mesenchymal stem cells demonstrating a novel mechanism 
of TGFβ signal regulation and recruitment in stem cells. Therefore, this study highlights the primary cilium as 
a potential target to enhance MSC recruitment and bone formation in orthopaedic disease but also for other 
pathologies involving TGFβ 1-induced MSC recruitment. Given the diverse roles of TGFβ 1 in many tissues 
throughout the body, these findings may have important implications for several other pathologies.
Methods
Cell culture. Human bone marrow mesenchymal stem cells (hMSCs) from 2 different donors were obtained 
from ATCC (ATCC, PCS-500-012), who obtained the original cells under their ethics agreement. hMSCs were main-
tained in growth medium consisting of DMEM low glucose medium, 10% Fetal Bovine Serum (FBS, South America 
origin, Labtech) and 1% Penicillin-Streptomycin (P/S). For all experiments, cells were used from passage 3 to 5.
Figure 7. SMAD3 signalling takes place at the primary cilium and is mediated by IFT. (a–d) Representative 
immunofluorescence images of p-SMAD3 in Scrambled (a,b) and IFT88 siRNA transfected cells (c,d) before 
and after treatment with 1 pg/ml TGFβ 1 for 30 minutes. Primary cilia were stained with anti-acetylated-α 
-tubulin (red, arrows), nuclei were stained with DAPI (blue) and p-SMAD3 protein is shown in green 
at the ciliary base region (arrowhead). Scale bars represent 5 μ m and 1 μ m (insert). (e–f) Analysis of the 
relative quantity of proteins at the (e) ciliary base region and (f) within the nucleus assessed by fluorescence 
intensities measurements of Scrambled and IFT88 transfected cells before treatment. (g–h) Analysis of the 
relative quantity of proteins at the (g) ciliary base region and (h) within the nucleus assessed by fluorescence 
intensities measurements of Scrambled and IFT88 transfected cells following treatment with 1 pg/ml TGFβ 1 
for 30 minutes. Both scrambled and IFT88 KD are normalised to their respective no TGFβ 1 treatment control. 
Statistical analysis student’s t-test. *p < 0.05, ***p < 0.001.
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Cell migration. Chemotaxis towards TGFβ 1 was analysed using a modified Boyden chamber assay (24 wells 
Millicell inserts, 0.8 μ m, Millipore). 10,000 cells were seeded within the inserts in a 24-well plate in DMEM with-
out serum. After 4 hours, the inserts were transferred to a new plate containing serum free growth medium sup-
plemented with 0.01 pg/ml to 10 ng/ml TGFβ 1 (recombinant human, R&D systems). Cell migration was allowed 
for 18 hours and cells were fixed with 10% formalin and stained with haematoxylin. After extensive rinsing, the 
inside of the inserts were cleaned using cotton buds and the membranes were cut and mounted with DPX mount-
ing medium. Migrated cells were quantified by bright field microscopy in at least 8 different fields of view at 20x 
and normalised to the number of cells migrated without TGFβ 1 supplementation (chemotactic index).
Cell proliferation. Human MSCs were seeded in 6 well plates at 30,000 cells/well, maintained for 2 days 
in growth medium followed by treatment with media containing 0.5% FBS supplemented with 0.01 pg/ml to 
20 ng/ml TGFβ 1. After 3 days, cells were rinsed twice with cold PBS and lysed on ice for 20 minutes with 100 μ l 
lysis buffer containing 0.2% v/v Triton X100, 10 mM Tris pH8 and 1 mM EDTA. Cells were detached using a cell 
scraper, vortexed thoroughly and stored at − 80 °C. The cell suspensions were homogenised using with a 21G 
needle before measuring DNA concentration using Quant-iT™ PicoGreen® dsDNA Assay Kit (Thermoscientific) 
following the manufacturer protocol.
Cell differentiation. Human MSCs were seeded in 6 wells plates at 30,000 cells/well and maintained in 
growth medium until 70% confluency is reached. The medium was then changed to osteogenic media containing 
0.5% serum, 3.25 nM Dexamethazone, 5 mM β -glycerophosphate and 25 μ M Ascorbic Acid. These concentrations 
are the minimum required to induce osteogenic differentiation61. TGFβ 1 was added to the medium at 0.1 pg/ml to 
20 ng/ml and the medium was replaced every 3 days for 14 days. Quantitative real-time PCR were performed with 
an ABI 7900 instrument (Applied Biosystems) using the protocol and primers described in Supplementary meth-
ods. For Alizarin red staining, cells were fixed at day 14 with 10% formalin for 15 minutes, washed and stained 
with 2% Alizarin red for 20 minutes and rinsed. Calcium ion quantification was performed using acidic extraction 
of Alizarin red based on a modified protocol from Gregory et al.62. Briefly, 10% acetic acid was added to the wells 
and incubated with shaking for 30 mins, the cell layer was scraped, transferred to a microcentrifuge tube and 
incubated at 85 °C for 10 minutes. Samples were then cooled on ice and centrifuged at 20,000 g for 15 minutes. 
500 μ l of the supernatant was mixed with 200 μ l 10% (v/v) ammonium hydroxide and absorbance was measured 
at 405 nm. Calcium ion concentration was determined using standards of Alizarin red given that one calcium ion 
binds to two molecules of Alizarin Red S63.
Immunostaining and co-localisation analysis. The localization of TGFβ 1 signalling components 
within MSCs was investigated through immunocytochemistry after 48 hours of serum starvation (DMEM, 0.5% 
FBS, 1%P/S). Cells were fixed and stained for acetylated α -tubulin staining to identify the primary cilium, TGFβ 
RII, TGFβ RI and the downstream effectors phosphorylated TGFβ RI (p-TGFβ RIS165), phosphorylated SMAD2 
(p-SMAD2), phosphorylated SMAD3 (p-SMAD3) and SMAD4 (Suppliers, references and dilution indicated in 
Supplementary methods). Coverslips were mounted with Fluoroshield-DAPI. To investigate the localisation of 
these components upon activation of the pathway, cells were treated with TGFβ 1 (recombinant human TGFβ 1, 
R&D Systems) for 30 minutes or 2 hours. All cells were imaged using an Olympus IX83 epifluorescence micro-
scope fitted with 100x objective and a Zeiss LSM710 META Confocal Laser Scanning microscope fitted with a 63x 
objective. Control samples without secondary antibody were performed to ensure that there is no bleed-through 
in the experimental conditions. Intensity profiles along the cilium have been performed using Zen or CellSens 
software by tracing a line across the length of the primary cilia and measuring intensity along this line. Average 
intensities in the ciliary region, nucleus and cytoplasm were measured in three independent experiments on at 
least 7 cilia per condition. Region of interest were selected manually using ImageJ freeware and the intensities per 
pixel averaged. Regarding p-SMAD3 intensities analysis in transfected cells after TGFβ 1 treatment, the cilia base 
region were selected automatically with ImageJ threshold tool for a minimum intensity of three times the average 
intensity in the cytoplasm (15 a.u.). The nuclear region were also selected automatically using the DAPI staining 
and the cytoplasmic region were selected manually close to the cilia and nucleus. Phospho-SMAD3 staining 
intensities were then measured in the regions of interest and both cilia and nucleus intensities were normalised 
to the intensity in the cytoplasm by removing the average intensity in the cytoplasm from each pixel of the region 
of interest. Measurements were performed in three different samples for at least 40 ciliated cells per condition.
Measuring levels of SMAD signalling. Quantitative analysis of p-SMAD2 and p-SMAD3 was performed 
using PathScan® Phospho-SMAD2 (Ser465/467)/Phospho-SMAD3 (Ser423/425) Sandwich ELISA Kit and 
PathScan® phospho-SMAD3 (Ser423/425) Sandwich ELISA Kit (Cell Signaling Technology). Cells were grown 
in 100 mm Petri dishes and lysed using the buffer provided (Cell Signaling Technology #9803) complemented 
with 1 mM PMSF. Cell lysates were homogenised by passing the lysate through a 25G needle at least 10 times and 
centrifuged at 14000 g for 15 minutes at 4 °C. Total protein concentration was determined by BCA (Pierce™ BCA 
Protein Assay Kit, Thermofisher) to ensure the same quantity of protein were loaded in each well (30 to 50 μ g). 
Briefly, SMAD2/3 Mouse Antibodies Coated Microwells were incubated with the sample diluted ½ in the sample 
buffer provided overnight at 4 °C. After rinsing, the wells were incubated with p-SMAD2/3 or p-SMAD3 Rabbit 
Detection Antibody for 1 hour at 37 °C. The presence of p-SMAD2/3 and p-SMAD3 were then detected with a 
HRP-linked secondary antibody and TMB substrate.
Primary cilia knockdown. The formation of functional primary cilia was inhibited by small-interfering 
RNA (siRNA)-mediated depletion of IFT88, an intraflagellar transport protein (IFT) required for functional 
ciliogenesis. hMSCs were transfected with 32 μ M siRNA targeting IFT88 (HSS111979, Invitrogen) or with a 
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scrambled siRNA (Stealth RNAi™ siRNA Negative Control, Medium GC, 12935300, Invitrogen) for 24 hours 
using Lipofectamine® RNAiMAX 1/250 (Invitrogen). Transfected MSC were maintained in DMEM 0.5% FBS for 
a further 24 hours before the cells were trypsinised to seed for experiments. Transfection efficiency was verified 
72 hours after transfection by quantitative real-time PCR (qPCR), Western Blot and Immunocytochemistry. qPCR 
for IFT88 mRNA was performed as described above. Western blot was performed as described in Supplementary 
methods for three different samples from two different experiments. Immunofluorescence were performed as 
described above for Acetylated-α -tubulin. Percentage of ciliated cells were determined and cilia length analysed 
by epifluorescence microscopy using an Olympus IX83 fitted with 100x objective. Cilia length were measured 
using Cellsens software (Olympus).
Statistics. All data are presented as average ± S.E.M. and analysed using GraphPad Prism 5. Statistically sig-
nificant differences were indicated as *p < 0.05, **p < 0.01, ***p < 0.001. For the dose-response studies one way 
Anova analysis were performed with Dunnett’s Multiple Comparison Test. All other analysis were performed 
using two-tailed unpaired student’s t-test. Regarding the migration assay, ELISA and intensities measurements 
of Ift88 KD cells, we observed a high variability between independent experiments and given the low TGFβ 1 
concentrations used induce a small but consistent effect, it was necessary to normalise the data to the controls for 
every single experiment.
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